VIVIMEDLABNSEVIVIMED LABS LIMITED· Chemicals - SpecialityHighNeutral
Announced Mon, 28 Sept, 2026 · 11:11 IST

Vivimed Labs 8th Committee of Creditors meeting scheduled for Sep 29, 2026

Nclt Insolvency AdmittedRegulatory & Legal View source PDFExplain this filing

VIVIMEDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹5.55
prior close
₹5.55
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
———-2.0+0.0+1.6+2.9+7.9+13.2+24.5————
Up moveDown movePending
AI summary

Vivimed Labs, currently under corporate insolvency resolution process following an NCLT order dated April 15, 2026, has informed exchanges about its 8th Committee of Creditors (CoC) meeting scheduled for September 29, 2026 via audio-visual means. The meeting will be held under IBBI insolvency regulations. Narayana Swamy, the Interim Resolution Professional, is overseeing the process. The filing is a pre-facto intimation as required under SEBI listing rules, informing markets ahead of the upcoming CoC meeting.

Likely market impact

Stock remains under insolvency process; outcome of next CoC meeting will shape resolution plan and shareholder recovery prospects